Type1Screen

01/06/2026

Thank-you Tilly for sharing your screening story with The Type1 Foundation.
There has never been a better time to screen!
Www.type1screen.org

31/05/2026

There was a wonderful buzz in the type 1 diabetes world last week when Tzield was the first immunotherapy approved for use in Australia for people with stage two, type 1 diabetes.
But was is an immunotherapy? And how does it work in type 1 diabetes?
Our friends at ATIC shared this fantastic explainer video last week to answer these questions!

The ATIC Community Engagement Panel has led the development of a new video resource designed to raise awareness among health professionals and the community about the benefits of immunotherapy for type 1 diabetes.

28/05/2026

The approval of Tzield in Australia means that there really has never been a better time to screen for type 1 diabetes.
We offer screening to anyone in Australia who has a family member with type 1 diabetes (and is aged over 2 years). You can register via our website www.type1screen.org

27/05/2026

Type1Screen's own Prof John Wentworth spoke to Channel 9's Sarah Abo on Today this morning about the TGA approval of Tzield. You can share John's excitement here: https://youtu.be/jmW7nqkOxh8?si=WM6vXDQde1Gph2C8

There's new hope this morning for diabetes patients, with a life-ch...

27/05/2026

More from our friends at Breakthrough T1D Australia on today's fantastic news!

Fantastic type 1 diabetes (T1D) news in Australia this morning: Tzield has been approved by the Therapeutic Goods Administration (TGA) for use in people aged 8+ years who are in stage 2 T1D!

Here’s why it’s so exciting:

🧪 Tzield (teplizumab) can delay the progression of T1D from stage 2 (before people start showing T1D symptoms) to stage 3 (when symptoms of T1D begin and people start needing insulin therapy).

☺️ On average, Tzield means an extra 2 years of life without insulin. That's an extra 2 years without the physical, emotional, financial and mental burdens of T1D.

💉 This is the first new drug approved for T1D in over 100 years, since the discovery of insulin!

🩸 People can only be found in the early stages of T1D through screening. That’s why Breakthrough T1D has been funding early detection and screening initiatives in Australia for many years and is a global leader in the field.

💰 Breakthrough T1D has funded the development of teplizumab for almost 4 decades, from the early discovery research to the landmark clinical trials that proved it could delay T1D progression.

🔓 Next up, Breakthrough T1D will be advocating for the therapy to be listed on the Pharmaceutical Benefits Scheme (PBS), so it can become subsidised and available for all people with stage 2 T1D who want to access it.

We'll share more about Tzield and what this means in the days to come – you can also click the link in the comments to learn more about this exciting news!

26/05/2026

Type1Screen are thrilled to share the news that Tzield (Teplizumab) has been approved for use in Australia in early-stage type 1 diabetes.
Tzield is the first new therapy approved for type 1 diabetes since insulin was discovered over 100 years ago and its approval represents a landmark change in the way that type 1 diabetes is treated.
Tzield reduces the immune system attack on the insulin making cells of the pancreas to allow people to continue to make their own insulin and delaying the need for insulin treatment and the physical and emotional challenges of living with type 1 diabetes.
The only way to know if you are eligible for Tzield is to be screened for type 1 diabetes antibodies. If you have a family member with type 1 diabetes, you can register for a free, at-home screening test at www.type1screen.org.
More information about the Tzield approval is available via the link in the comment section.

Type1Screen is supported by Breakthrough T1D Australia

21/05/2026

Why does early detection of type 1 diabetes matter?

There are now emerging treatments and clinical trials aiming to slow the progression of early-stage type 1 diabetes before insulin dependence develops. Research in this area is moving fast and knowing your risk may open the door to monitoring, education, and future opportunities to participate in clinical trials.
If you have a family member with type 1 diabetes, now is the time to explore screening.
Learn more at www.type1screen.org

21/05/2026

Reminder to our healthcare professional followers that this event is happening next week. Register now!

Join us on Tuesday 26 May for a summit on type 1 diabetes (T1D) early detection programs and emerging immunotherapies.

19/05/2026

Today on World Clinical Trials Day, the team at Type1Screen would like to say a heartfelt thank you to everyone who takes part in clinical trials and research studies. 💙
Progress in type 1 diabetes screening, prevention, and treatment is only possible because individuals and families choose to participate in research. By volunteering your time and sharing your experiences, you are helping shape a future where type 1 diabetes can be detected earlier, treated better, and one day prevented.
Every blood test, study visit, survey, and conversation contributes to improving outcomes for people and families impacted by type 1 diabetes.
To all research participants, families, researchers, clinicians, and supporters, our heartfelt thanks for helping drive progress and hope forward.